Ou Jingfeng, Zhang Jin, Alswadeh Momen, Zhu Zhenglin, Tang Jijun, Sang Hongxun, Lu Ke
Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Faculty of Computer Science and Control Engineering, Shenzhen University of Advanced Technology, Shenzhen, China.
Bone Res. 2025 Apr 22;13(1):48. doi: 10.1038/s41413-025-00423-2.
Osteoarthritis (OA) is a degenerative joint disease with significant clinical and societal impact. Traditional diagnostic methods, including subjective clinical assessments and imaging techniques such as X-rays and MRIs, are often limited in their ability to detect early-stage OA or capture subtle joint changes. These limitations result in delayed diagnoses and inconsistent outcomes. Additionally, the analysis of omics data is challenged by the complexity and high dimensionality of biological datasets, making it difficult to identify key molecular mechanisms and biomarkers. Recent advancements in artificial intelligence (AI) offer transformative potential to address these challenges. This review systematically explores the integration of AI into OA research, focusing on applications such as AI-driven early screening and risk prediction from electronic health records (EHR), automated grading and morphological analysis of imaging data, and biomarker discovery through multi-omics integration. By consolidating progress across clinical, imaging, and omics domains, this review provides a comprehensive perspective on how AI is reshaping OA research. The findings have the potential to drive innovations in personalized medicine and targeted interventions, addressing longstanding challenges in OA diagnosis and management.
骨关节炎(OA)是一种具有重大临床和社会影响的退行性关节疾病。传统的诊断方法,包括主观临床评估以及X射线和磁共振成像(MRI)等成像技术,在检测早期OA或捕捉细微关节变化方面往往存在局限性。这些局限性导致诊断延迟和结果不一致。此外,组学数据分析面临生物数据集的复杂性和高维度挑战,难以识别关键分子机制和生物标志物。人工智能(AI)的最新进展为应对这些挑战提供了变革潜力。本综述系统地探讨了AI在OA研究中的整合,重点关注诸如基于电子健康记录(EHR)的AI驱动早期筛查和风险预测、成像数据的自动分级和形态分析以及通过多组学整合发现生物标志物等应用。通过整合临床、成像和组学领域的进展,本综述全面阐述了AI如何重塑OA研究。这些发现有可能推动个性化医疗和靶向干预的创新,解决OA诊断和管理中长期存在的挑战。